[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xtl Biopharma ADR (XTLB)

Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,949
  • Shares Outstanding, K 2,204
  • Annual Sales, $ 450 K
  • Annual Income, $ -1,030 K
  • EBIT $ 0 M
  • EBITDA $ -2 M
  • 60-Month Beta 1.64
  • Price/Sales 5.77
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.30 +13.48%
on 04/28/26
4.87 -46.41%
on 04/29/26
+0.23 (+9.66%)
since 04/15/26
3-Month
2.20 +18.64%
on 03/10/26
4.87 -46.41%
on 04/29/26
-0.96 (-26.80%)
since 02/13/26
52-Week
2.12 +23.09%
on 01/02/26
10.28 -74.61%
on 10/08/25
-1.95 (-42.76%)
since 05/15/25

Most Recent Stories

More News
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying...

XAIR : 0.4979 (+5.94%)
XTLB : 2.61 (-3.33%)
XTL Flat on buying SOCIAL PROXY

XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) announced today it has entered into a definitive share purchase ...

XTLB : 2.61 (-3.33%)

Business Summary

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company developing drugs against hepatitis.

See More

Key Turning Points

3rd Resistance Point 2.73
2nd Resistance Point 2.67
1st Resistance Point 2.64
Last Price 2.61
1st Support Level 2.55
2nd Support Level 2.49
3rd Support Level 2.46

See More

52-Week High 10.28
Fibonacci 61.8% 7.16
Fibonacci 50% 6.20
Fibonacci 38.2% 5.24
Last Price 2.61
52-Week Low 2.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.